Abstract
1121 Tigilanol tiglate is a naturally occurring small molecule oncolytic that effectively ablates tumors via intratumoural injection and can enhance response to immune checkpoint blockade
Journal for ImmunoTherapy of Cancer, Vol.10(Supplement 2), pp.A1165-A1165
Society for Immunotherapy of Cancers (SITC) Annual Meeting, 37th (Boston, United States, 08-Nov-2022–12-Nov-2022)
2022
Abstract
No abstract available.
Details
- Title
- 1121 Tigilanol tiglate is a naturally occurring small molecule oncolytic that effectively ablates tumors via intratumoural injection and can enhance response to immune checkpoint blockade
- Authors
- Jason Cullen (Author) - QIMR Berghofer Medical Research InstitutePei-Yi Yap (Author) - QIMR Berghofer Medical Research InstituteBlake Ferguson (Author) - QIMR Berghofer Medical Research InstituteZara Bruce (Author) - QIMR Berghofer Medical Research InstituteMotoko Koyama (Author) - Fred Hutch Cancer CenterHerlina Handoko (Author) - QIMR Berghofer Medical Research InstituteJacinta L Simmons (Author) - QIMR Berghofer Medical Research InstituteJenny Johns (Author) - QIMR Berghofer Medical Research InstituteMarjorie D'Souza (Author) - QIMR Berghofer Medical Research InstituteNatasa Broit (Author) - QIMR Berghofer Medical Research InstitutePraphaporn Stewart (Author) - University of the Sunshine Coast, Queensland, Centre for BioinnovationDaniel Shelley (Author) - University of the Sunshine Coast, Queensland, Technical and Work Integrated Learning (WIL) Operations - LegacyTracey McMahon (Author) - University of the Sunshine Coast, Queensland, GeneCology Research Centre - LegacySteven Ogbourne (Author) - QBiotics Group Ltd.Yi Chieh Lim (Author) - Danish Cancer SocietyGiovanni Appendino (Author) - Università degli Studi del Piemonte Orientale “Amedeo Avogadro”Victoria Gordon (Author) - QBiotics Group Ltd.Paul W Reddell (Author) - QBiotics Group Ltd.Glen M Boyle (Author) - QIMR Berghofer Medical Research InstitutePeter G Parsons (Author) - QIMR Berghofer Medical Research Institute
- Publication details
- Journal for ImmunoTherapy of Cancer, Vol.10(Supplement 2), pp.A1165-A1165
- Conference details
- Society for Immunotherapy of Cancers (SITC) Annual Meeting, 37th (Boston, United States, 08-Nov-2022–12-Nov-2022)
- Publisher
- BMJ Group
- Date published
- 2022
- DOI
- 10.1136/jitc-2022-SITC2022.1121
- ISSN
- 2051-1426
- Copyright note
- © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
- Organisation Unit
- GeneCology Research Centre - Legacy; Technical and Work Integrated Learning (WIL) Operations - Legacy; School of Science, Technology and Engineering; Centre for Bioinnovation
- Language
- English
- Record Identifier
- 99720598302621
- Output Type
- Abstract
Metrics
6 File views/ downloads
88 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Web Of Science research areas
- Immunology
- Oncology
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites